【EirGenix】February 2026 Revenue: NT$85M (YoY +100.6%)
NQ Score
60/100
N1 Content Completeness
3
AI Summary (NQ-processed)
EirGenix, Inc. has released its financial report for February 2026, posting a monthly revenue of NT$85 million, which represents a 100.6% growth compared to the same period last year. This figure indicates the biotechnology and medical care company's strong expansion in its CDMO business.
AI analysis data is not yet available.